Search research articles
Contact Us
Filters
Showing results (71-80 of 110) with videos related to
Page
of 11
Sort By:
Oncology
|
October 9, 2008
Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer
Nam P Nguyen, Paul Vos, Howard Lee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 31, 2012
Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer
Arya Amini, Jinzhong Yang, Ryan Williamson, et al.
Clinical and Translational Radiation Oncology
|
March 29, 2021
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study
Wang Jing, Yufei Liu, Hui Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 23, 2012
Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era
Arya Amini, Lianchun Xiao, Pamela K Allen, et al.
Science Advances
|
May 20, 2020
Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy
Joseph D Butner, Dalia Elganainy, Charles X Wang, et al.
Practical Radiation Oncology
|
September 18, 2016
Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions
Cameron W Swanick, Pamela K Allen, Randa Tao, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 18, 2025
The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity
Célia Bienassis, Omar I Vivar, Yun Hu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 3, 2010
Esophageal cancer dose escalation using a simultaneous integrated boost technique
James Welsh, Matthew B Palmer, Jaffer A Ajani, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2024
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies
Joe Y Chang, Xinyan Xu, Girish S Shroff, et al.
Journal for Immunotherapy of Cancer
|
June 26, 2020
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
Dawei Chen, Hampartsoum B Barsoumian, Grant Fischer, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 110) with videos related to
Sort By:
Page
of 11
Oncology
|
October 9, 2008
Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer
Nam P Nguyen, Paul Vos, Howard Lee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 31, 2012
Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer
Arya Amini, Jinzhong Yang, Ryan Williamson, et al.
Clinical and Translational Radiation Oncology
|
March 29, 2021
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study
Wang Jing, Yufei Liu, Hui Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 23, 2012
Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era
Arya Amini, Lianchun Xiao, Pamela K Allen, et al.
Science Advances
|
May 20, 2020
Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy
Joseph D Butner, Dalia Elganainy, Charles X Wang, et al.
Practical Radiation Oncology
|
September 18, 2016
Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions
Cameron W Swanick, Pamela K Allen, Randa Tao, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 18, 2025
The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity
Célia Bienassis, Omar I Vivar, Yun Hu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 3, 2010
Esophageal cancer dose escalation using a simultaneous integrated boost technique
James Welsh, Matthew B Palmer, Jaffer A Ajani, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2024
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies
Joe Y Chang, Xinyan Xu, Girish S Shroff, et al.
Journal for Immunotherapy of Cancer
|
June 26, 2020
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
Dawei Chen, Hampartsoum B Barsoumian, Grant Fischer, et al.
Page
of 11